This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Price, N.D. et al. Nat. Biotechnol. 35, 747–756 (2017).
Chen, R. et al. Cell 148, 1293–1307 (2012).
David, L.A. et al. Genome Biol. 15, R89 (2014).
Smarr, L. Biotechnol. J. 7, 980–991 (2012).
Vogt, H., Green, S. & Broderson, J. Nat. Biotechnol. 36, 678–680 (2018).
Collins, F.S. & Varmus, H. N. Engl. J. Med. 372, 793–795 (2015).
Hood, L., Lovejoy, J.C. & Price, N.D. BMC Med. 13, 4 (2015).
Schork, N.J. Nature 520, 609–611 (2015).
Jørgensen, T. et al. Br. Med. J. 348, g3617 (2014).
Rice, T. et al. Circulation 105, 1904–1908 (2002).
Bouchard, C. et al. PLoS One 7, e37887 (2012).
Diabetes Prevention Program Research Group. Lancet 374, 1677–1686 (2009).
Li, G. et al. Lancet 371, 1783–1789 (2008).
American Diabetes Association. Diabetes Care 37 (Suppl. 1), S81–S90 (2014).
Menke, A., Casagrande, S., Geiss, L. & Cowie, C.C. J. Am. Med. Assoc. 314, 1021–1029 (2015).
Zhang, X. et al. Diabetes Care 33, 1665–1673 (2010).
Holick, M.F. et al. J. Clin. Endocrinol. Metab. 97, 1153–1158 (2012).
Danaei, G. et al. PLoS Med. 6, e1000058 (2009).
Green, R.C. et al. N. Engl. J. Med. 361, 245–254 (2009).
Yong, P.L., Sanders, R.S. & Olsen, L. The Healthcare Imperative: Lowering Costs and Improving Outcomes: Workshop Series Summary. (US National Academies Press, Washington, DC, 2010).
Xu, X. et al. Int. J. Obes (Lond). 42, 794–800 (2018).
Hollands, G.J. et al. Br. Med. J. 352, i1102 (2016).
Piening, B.D. et al. Cell Syst. 6, 157–170.e8 (2018).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
L.H. and N.D.P. are cofounders of Arivale and hold stock in the company. N.D.P. is on the Arivale Board of Directors; L.H. is chair and G.S.O. a member of Arivale's Scientific Advisory Board. A.T.M. and J.C.L. are employees of Arivale and have stock options in the company, as do J.C.E., G.G. and G.S.O.
Rights and permissions
About this article
Cite this article
Magis, A., Earls, J., Glusman, G. et al. Reply to "Precision medicine in the clouds". Nat Biotechnol 36, 680–682 (2018). https://doi.org/10.1038/nbt.4211
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.4211
This article is cited by
-
Aging biomarkers and the measurement of health and risk
History and Philosophy of the Life Sciences (2021)